Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Clin Cancer Res. 2013 Nov 15;20(3):764–775. doi: 10.1158/1078-0432.CCR-13-2287

Table 2.

Non-serous cases with HR mutations.

Histology ID Grade Germline HR mutationa Somatic HR mutation(s)a Somatic PTEN mutation(s)a
Clear cell UW400 3 CHEK2 p.S428F
UWf14 3 BRCA2 p.S368X
UW420 3 CHEK2 del exon 1–7
UW408 3 ATM c.5441delT PTEN c.678delC
UW358 3 BRCA1 1135insA
BRIP1 c.3260insA
MRE11A c.1196insTT
PTEN c.968insA
Endometrioid UW383 1 BRIP1 p.R798X PTEN c.955delACTT
UW381 1 ATM c.3284(+1)G>C splice
UW131 2 BRCA2 p.R2494X
UW341 2 BRCA1 dup exon 21–24
UW165 3 BRCA1 187delAG
UWf2 3 BRCA2 3034delAAAC
UW132 3 RAD51D c.580delA PTEN c.389delG
Carcinosarcoma UWf77 3 BRCA1 2080delA
UW435 3 FAM175A c.1106insG
UW407 3 RAD51C c.706(−2) A>G splice
UW124 3 BRCA1 3481delA
Malignant Brenner’s UW96 3 FAM175A c.1106insG
a

BRCA1 and BRCA2 mutations were annotated using BIC designation (http://research.nhgri.nih.gov/bic/, reference sequences: BRCA1 GenBank U14680; BRCA2 GenBank U43746); all other mutations were annotated using HGVS nomenclature.